USANA And ConsumerLab.com See Eye To Eye On Visionex
In a recent study on eye health supplements, ConsumerLab.com determined that USANA's Visionex® contains at least 100 percent of the claimed amounts of lutein and claimed amounts of zeaxanthin listed on the label; satisfies California's Proposition 65 levels for lead contamination; adheres to recommended United States Pharmacopeia (USP) disintegration parameters; and meets Food and Drug Administration (FDA) labeling requirements.
"We know our products contain exactly what is listed on the label, but it's critical to have third-party confirmation and approval," says Dan Macuga, USANA chief communications officer. "We're proud of how well our products have performed in independent testing from reputable third-party organizations such as ConsumerLab.com."
This review tested similar eye health products from various nutritional supplement manufacturers to determine whether they in fact contained the right amounts of lutein and zeaxanthin on their labels. The review can be found on the company's website at www.consumerlab.com.
In light of new FDA warnings against potentially unsafe supplements available on the market, ConsumerLab.com testing helps consumers and healthcare professionals make better decisions and more informed recommendations when it comes to supplements.
"There is a lot of research and development that go into each of our products. Lutein and zeaxanthin are crucial for eye health-that's why they are essential ingredients in Visionex," states Dr. Carsten Smidt, USANA vice president of research and development. "We use the highest quality ingredients possible, and we have pharmaceutical quality protocols in place that guarantee potency and purity."
Since 1999, ConsumerLab.com has tested more than 3,200 products, 350 different brands and nearly every type of popular supplement in order to help consumers and healthcare professionals identify the best quality health and nutrition products. ConsumerLab.com is also the only third-party verification group that freely publishes its testing methods and quality criteria/standards.
More USANA news
USANA Q3 Net Sales Fall 4% to $206 Million as Core Customers Slide; Company Trims 2026 Outlook
SALT LAKE CITY, Utah - November 3, 2026 USANA Health Sciences reported third-quarter 2026 net sales of $206 million on November 3, down 4 percent from $214 million a year earlier...
USANA Reports Second Quarter Sales of 223 Million Dollars and Net Loss on Impairment
SALT LAKE CITY, Utah -- August 4, 2026 USANA Health Sciences reported second-quarter 2026 net sales of 223 million dollars, down 5% from 236 million dollars a year earlier. The...
USANA Reports Flat First Quarter Net Sales of 250 Million Dollars
SALT LAKE CITY, Utah -- May 5, 2026 USANA Health Sciences reported fiscal first-quarter 2026 net sales of 250 million dollars, unchanged from the year-earlier quarter, as growth...
USANA Swings to Fourth-Quarter Loss as Active Customers Fall to 387,000
SALT LAKE CITY, Utah -- February 17, 2026 USANA Health Sciences reported fourth-quarter 2025 net sales of 226.2 million dollars, up 6 percent from 213.6 million dollars a year...
USANA Chief Executive Jim Brown Steps Down; Kevin Guest Returns as CEO
SALT LAKE CITY, Utah -- January 8, 2026 USANA Health Sciences said Jim Brown has stepped down as chief executive officer and president and that Kevin Guest, the company's...